Trimurthi Ltd
BSE:536565
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Trimurthi Ltd
Other Current Assets
Trimurthi Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Trimurthi Ltd
BSE:536565
|
Other Current Assets
₹28m
|
CAGR 3-Years
69%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
K
|
Kretto Syscon Ltd
BSE:531328
|
Other Current Assets
₹20m
|
CAGR 3-Years
593%
|
CAGR 5-Years
90%
|
CAGR 10-Years
31%
|
|
|
B
|
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
|
Other Current Assets
₹112.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dipna Pharmachem Ltd
BSE:543594
|
Other Current Assets
₹581.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hemant Surgical Industries Ltd
BSE:543916
|
Other Current Assets
₹30.1m
|
CAGR 3-Years
44%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
A
|
Achyut Healthcare Ltd
BSE:543499
|
Other Current Assets
₹0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Trimurthi Ltd
Glance View
Trimurthi Ltd. operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The firm is primarily engaged in the business of pharmaceutical distribution and retail pharmacy. Its segments include Pharma Business, Financial Activity, Investment Activity and Trading in Shares. The Company’s services include a distribution network for pharmaceutical products, retail pharmacy and marketing. Its products include ULCIZOL, OXYMIN, Volivia Gold, Conplus, Oriflox, Treb-DSR, ACLO-P and LAMITAB. The firm has its pharmacy retail outlets in Himayath Nagar and Inderbagh, Sultan Bazar in Hyderabad. The company has its operations in the state of West Bengal and has its presence in the eastern part of India. Trimurthi Pharmaceuticals (India) Private Limited is the Company’s subsidiary.
See Also
What is Trimurthi Ltd's Other Current Assets?
Other Current Assets
28m
INR
Based on the financial report for Jun 30, 2024, Trimurthi Ltd's Other Current Assets amounts to 28m INR.
What is Trimurthi Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
11%
Over the last year, the Other Current Assets growth was 640%. The average annual Other Current Assets growth rates for Trimurthi Ltd have been 69% over the past three years , 11% over the past five years .
